Evidence map›Paper›PMID 40051560›Full record

ArticleFrontiers in pharmacology2025

Pharmacological targets and therapeutic mechanisms of Arabic gum in treating diabetic wounds: insights from network pharmacology and experimental validation.

Langjie Chai, Danyang Chen, Lili Ye, Pan Peng, Haijie Wang, Nouf Al Saleh, Nader S Al-Kenani, Jia Guo, Qianqian Li, Liang Guo

Abstract read
In one paragraph

Article in Frontiers in pharmacology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. Article
  2. Review
  3. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Langjie Chai *Department of Plastic Surgery, Zhongnan Hospital of Wuhan University, Wuhan, China.
Danyang Chen *Department of Plastic Surgery, Zhongnan Hospital of Wuhan University, Wuhan, China.
Lili Ye *Department of Plastic Surgery, Zhongnan Hospital of Wuhan University, Wuhan, China.
Pan PengDepartment of Plastic Surgery, Zhongnan Hospital of Wuhan University, Wuhan, China.
Haijie WangDepartment of Plastic Surgery, Zhongnan Hospital of Wuhan University, Wuhan, China.
Nouf Al SalehSmart Hybrid Materials Laboratory (SHMs), Division of Physical Science and Engineering, King Abdullah University of Science and Technology (KAUST) Thuwal, Thuwal, Saudi Arabia.
Nader S Al-KenaniDepartment of Orthopedic, Prince Sultan Bin Abdulaziz Humanitarian City, Riyadh, Saudi Arabia.
Jia GuoDepartment of Plastic Surgery, Zhongnan Hospital of Wuhan University, Wuhan, China.
Qianqian LiDepartment of Plastic Surgery, Zhongnan Hospital of Wuhan University, Wuhan, China.
Liang GuoDepartment of Plastic Surgery, Zhongnan Hospital of Wuhan University, Wuhan, China.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background and objectives: On account of the long-term inflammatory microenvironment, diabetic wounds are challenging to heal in which advanced glycation end products are considered important factors hindering the healing of diabetic wounds. Gum Arabic has demonstrated significant potential in the treatment of various diseases owing to its anti-inflammatory and antioxidant properties. Nonetheless, there is still insufficient research on the role of Arabic gum in facilitating diabetic wounds healing and its mechanisms. This study aims to investigate the pharmacological targets and therapeutic mechanisms of Arabic Gum on diabetic wound healing by adopting network pharmacology, molecular docking, and experimental validation. Methods: Key active components of Arabic Gum and disease targets were identified through network pharmacology and bioinformatics. GO/KEGG enrichment was performed to identify critical pathways. Cytoscape and AutoDock were used for targets prediction and molecular docking validation. Results: Network pharmacology analysis identified key targets, encompassing HSP90AA1, STAT3, and PRKCB, involved in the AGEs-NF-κB-NLRP3 signaling axis. Molecular docking demonstrated strong binding affinity between AG components and these targets. Conclusion: This study provides new insights into diabetic wound repair and suggests that AG is a promising therapeutic agent for improving diabetic wound healing.

Indexed as

advanced glycation end productsAGEs-NF-κB-NLRP3 axisArabic gumdiabetic wound healingnetwork pharmacology

Identifiers

PMID40051560
PMCPMC11882529

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.